The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Pilot study of cisplatin, 5-fluorouracil, and a taxane (TPF) for advanced squamous cell carcinoma (SCC) of the penis.
R. Salvioni
No relevant relationships to disclose
N. Nicolai
No relevant relationships to disclose
L. Piva
No relevant relationships to disclose
M. Catanzaro
No relevant relationships to disclose
T. Torelli
No relevant relationships to disclose
D. Biasoni
No relevant relationships to disclose
S. Stagni
No relevant relationships to disclose
A. Milani
No relevant relationships to disclose
A. Necchi
No relevant relationships to disclose